Vijaya Diagnostic Centre is the largest integrated diagnostic chain in south India, with 123 state-of-the-art centers spread across 20 cities. In the last 5 years, the company recorded revenue and PAT CAGR of 12% and 16.5%, respectively, and it is expected to see revenue and PAT CAGR of 16% and 26%, over FY23-25, says Sandeep Raina of Nuvama Professional Clients.

► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes 
► Twitter - https://www.twitter.com/economictimes
► LinkedIn - https://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews

Fundamental Radar: Prospects strong for Vijaya Diagnostic to outperform peers

The company reported a net profit of Rs 17.55 crore during the April-June quarter of the last fiscal.

Vijaya Diagnostic Q1 net profit up 49.7% to Rs 26.2 crore

With higher contribution from radiology, B2C focus, it commands best-in-industry Ebitda margin, which we believe would continue.

Vijaya Diagnostic Q4 Results Review - Non-Covid Patient Footfall Sturdy: ICICI Securities

Shares of Thyrocare Technologies were trading 7.33 per cent higher at Rs 751.45. Vijaya Diagnostic Centre was up 5.33 per cent at Rs 501.65. Samsrita Labs jumped 5 per cent while shares of Dr Lalchandani Labs advanced 4 per cent

Thyrocare, Vijaya, other diagnostics shares jump up to 7% amid Covid scar

Vijaya Diagnostic Centre Ltd, South Indian Bank Ltd, KPIT Technologies Ltd and Indian Bank are among the other gainers in the BSE’s ‘A’ group today, 21 October 2022.

Finolex Cables Ltd leads gainers in ‘A’ group

Saurabh Mukherjea is the founder and CEO of Marcellus. By exiting GAEL, Marcellus added Vijaya Diagnostic Centre which debuted on the stock market last year.

Team Saurabh Mukherjea exits from this multibagger stock; gains 500% in 3 yrs

Team Saurabh Mukherjea in the newsletter pointed out two key competitive advantages of Vijaya Diagnostic: Customer convenience and quality of the diagnosis

Team Saurabh Mukherjea latest stock pick is down 18% from IPO price. Do you own?

Apcotex Industries Ltd, Vijaya Diagnostic Centre Ltd, Dish TV India Ltd and JM Financial Ltd are among the other gainers in the BSE’s ‘A’ group today, 23 September 2022.

Schneider Electric Infrastructure Ltd leads gainers in ‘A’ group

Vijaya Diagnostic Centre Ltd is a local firm in the healthcare industry with a market worth of Rs. 4,191.42 crore.

Small cap healthcare stock shall pay 100% dividend soon: Check record date

Vijaya Diagnostic Centre Q1 Review - Healthy Recovery In Non-Covid Business: ICICI Securities

Vijaya Diagnostic Q1 Review - Healthy Recovery In Non-Covid Business: ICICI Securities

Vijaya Diagnostic Centre Ltd registered volume of 4.85 lakh shares by 14:19 IST on NSE, a 9.97 fold spurt over two-week average daily volume of 48645 shares

Volumes spurt at Vijaya Diagnostic Centre Ltd counter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Vijaya Diagnostic Centre is an India-based diagnostic network company providing professional services ranging from  health checkups, home sample collection and corporate wellness.